The ARUTIS Study (Anglia Ruskin University Trial of the Intuitive System)
ARUTIS
1 other identifier
interventional
120
1 country
1
Brief Summary
The goal of this double-masked randomised controlled trial (RCT) is to assess the symptoms of visual stress (VS), reading speed and changes in behaviour / academic performance, when wearing optimal Precision Tinted Lenses compared to sub-optimal Precision Tinted Lenses (PTLs). In participants ages 9-18 years. Participants, parents and researchers will be masked until the end of the trial. Participants will be randomised into two groups A and B. 50% of participants will receive the optimal PTL where the other 50% will receive the sub-optimal PTL. Participants will be asked to wear the PTLs for one month. Followed by one month of no wear. After which, participants will receive the second pair of PTLs to wear for one month. Participants will need to fill out a symptom dairy everyday from the day of recruitment until the end of the trial. A symptom questionnaire will need to be filled out as baseline at recruitment and the end of each month of wear. An academic behaviour survey will also need to be filled out at baseline by parents and teachers at recruitment and the end of each month of wear. At the end of the three months unmasking will occur and participants will be given the PTL that demonstrate the greatest reduction in VS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedStudy Start
First participant enrolled
October 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedOctober 23, 2023
September 1, 2023
10 months
October 17, 2023
October 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Comparing symptom scores with symptom diaries reported under the two different treatment conditions
Participants will be requiured to fill out a daily diary from day of recruitment to the end of the trial.
3 months
Comparing symptom scores with questionnaires reported under the two different treatment conditions.
Participants will be required to fill out symptom questionnaires at baseline and at the end of each month wear.
3 months
Secondary Outcomes (2)
Identify the change in reading speed for participants (if any) when wearing PTLs, by analysing the results of the Wilkins Rate of Reading test (WRRT).
3 months
Identify the academic/behavioural change (if any) in participants when wearing PTLs, by analysing a survey completed by parents/guardians and teachers.
3 months
Study Arms (2)
Optimal Precision Tinted Lenses (PTL)
EXPERIMENTAL1. The participant is asked to describe any perceptual distortion and discomfort of the text in the colorimeter. 2. At each of the 12 hues in turn the saturation of colour is increased from white to modest saturation (30) and after 5s returned to white. The participant is asked to compare the coloured text with the white and report any differences in the distortion/discomfort. 3. At the best of the 12 hues, the participant adjusts the saturation to optimise the clarity and comfort of the text (comfort is more important than clarity). 4. At this saturation, the hue is adjusted by small amounts and re-optimised. The saturation is then minimised. 5. At the re-optimised hue/saturation, the brightness is reduced to assess its effects on comfort. If the lower brightness is preferred the saturation is increased slightly to see if the high brightness is better tolerated.
Sub-Optimal Precision Tinted Lenses (PTL)
EXPERIMENTALThe sub-optimal colour will be chosen as a colour of similar saturation to the optimal colour but differing in u'v' colour space by 0.07. Two colours of equal radial distance from the optimal colour will be considered. The colour that shares the name of the optimal colour or appears most similar will be chosen. After colorimetry, participants will choose a spectacle frame. Two pairs of PTLs will be made up by the manufacturing opticians, one to the optimal colour and the other to a slightly sub-optimal colour.
Interventions
Tinted coloured lenses with UV protection within spectacle frames with the intension to help reduce the symptoms of Visual stress.
Eligibility Criteria
You may qualify if:
- Age 9-18y.
- Meet diagnostic indicators for visual stress (see below)
- Consent (parent and participant to attend for optometric testing and participate in research.
- Do not anticipate moving from the area in the next 3 months
- Diagnostic indicators for visual stress
- At least three of the following six typical symptoms:
- Words Move
- Words Merge
- Patterns or shadows in text (e.g., "rivers")
- Text seems to stand out in 3-D above the page
- Words or letters fade or darken
- Discomfort with certain artificial lights and flicker
- And "At least two of the following three signs from investigations:
- Voluntary unprompted use of an overlay for 3 months or more
- Overlay improves performance at the WWRT BY ≥15%
- +1 more criteria
You may not qualify if:
- History of wearing precision tinted lenses.
- Ocular pathology, systemic pathology that is likely to worsen in the timescale of the study or cause transient blur (e.g., diabetes) or photosensitive epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anglis Ruskin University
Cambridge, RM2 6DH, United Kingdom
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2023
First Posted
October 23, 2023
Study Start
October 30, 2023
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
October 23, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Data will be available after the trial has been completed. Which will be in approximately 12 months. Data will be available for as long as necessary.
The study will conform to the tenets of the Declaration of Helsinki and will be registered in a clinical trials registry. When the analysis is complete, anonymised data will be stored in a publicly accessible data repository. Full informed consent will be obtained from participants and parents/guardians. Ethical approval was granted from the Anglia Ruskin University Faculty Research Ethics Panel (FREP).